Headline
The latest stories from AHA Today.
Launch prices for new brand-name prescription drugs increased 20% per year between 2008 and 2021, according to a study reported yesterday in JAMA.
AHA today launched a members-only resource bringing together the latest information and AHA efforts to hold health plans accountable
The Food and Drug Administration Friday released an updated checklist to help clinicians screen patients for potential drug interactions before prescribing the Pfizer antiviral pill Paxlovid.
The AHA today joined the U.S. Chamber of Commerce and American Medical Association in urging the 6th Circuit Court of Appeals to overturn a district court decision that refused to allow a case involving the Public Readiness and Emergency Preparedness Act of 2005 to proceed in federal court and sent…
Food and Drug Administration Commissioner Robert Califf said U.S. supplies now exceed pre-pandemic levels.
A Food and Drug Administration advisory committee yesterday recommended the agency authorize emergency use of the Novavax COVID-19 vaccine for adults.
The FTC will launch an inquiry into the prescription drug middleman industry.
Seae Ventures has launched a $107 million fund to invest in women and Black, Indigenous and other historically marginalized entrepreneurs.
AHA yesterday urged the Centers for Medicare & Medicaid Services to extend enforcement discretion for the No Surprises Act regulatory requirement.
Sen. Kevin Cramer, R-N.D., yesterday introduced AHA-supported legislation that would direct the Government Accountability Office to study the travel nursing industry’s business and payment practices, including their impact on workforce shortages and potential price gouging during the COVID-19…